GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases
Interventions: DRUG: GRN1005|DRUG: Trastuzumab|DRUG: 18F-FLT
Sponsor: Angiochem Inc